MBX Biosciences, Inc. Common Stock (MBX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $35.04
• Market Cap: $1.60B
• P/E Ratio: 4.65
• EPS: $7.67
• 52-Week High: $44.89
• 52-Week Low: $4.81

Market Sentiment

MBX Biosciences, Inc. Common Stock currently has a Bullish sentiment score of 0.25.

About MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical firm based in Carmel, Indiana, dedicated to the discovery and development of cutting-edge precision peptide therapies targeting endocrine and metabolic disorders. Utilizing its proprietary technology platform, MBX is vigorously advancing its innovative therapeutic candidates through extensive clinical trials. By concentrating on critical unmet medical needs in its therapeutic areas, the company is well-positioned to achieve substanti...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for MBX Biosciences, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MBX pay dividends?

MBX Biosciences, Inc. Common Stock (MBX) does not currently pay a regular dividend.

What is MBX's P/E ratio?

MBX Biosciences, Inc. Common Stock has a price-to-earnings (P/E) ratio of 4.65.

What is MBX's market cap?

MBX Biosciences, Inc. Common Stock (MBX) has a market capitalization of $1.60B with a current stock price of $35.04.